{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:45:09Z","timestamp":1794361509768,"version":"4.9.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The purpose of this mini review is to describe metabolomics in cerebrospinal fluid (CSF) and its potential in aneurysmal subarachnoid hemorrhage (aSAH). In brain injury, patients\u2019 micro dialysis enables detecting biochemical change in brain tissue. Indicators for ischemia were detected such as lactate, pyruvate, glucose, and glutamate. In aSAH patients, the pathophysiology and the factor for poor outcome are not completely understood yet. Routine use of biomarkers in CSF, particularly in aSAH patients, is still lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This mini review was performed on the role of metabolomics alterations after aneurysmal subarachnoid hemorrhage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified five clinical studies that addressed metabolomics in patients with aneurysmal subarachnoid hemorrhage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is increasing evidence suggesting that biomarkers can give insight in the pathogenesis and can serve as an outcome predictor. In this mini review, we present a brief overview of metabolomics profiling in neuroscience and wish to discuss the predictive and therapeutic value in aSAH patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13760-023-02266-2","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T17:01:57Z","timestamp":1682874117000},"page":"2111-2114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CSF metabolomics alterations after aneurysmal subarachnoid hemorrhage: what do we know?"],"prefix":"10.1007","volume":"123","author":[{"given":"Wing Mann","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-0910","authenticated-orcid":false,"given":"Franziska A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondra","family":"Petr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,30]]},"reference":[{"issue":"5","key":"2266_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","volume":"76","author":"NCH Etminan","year":"2019","unstructured":"Etminan NCH, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A (2019) Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 76(5):588\u2013597","journal-title":"JAMA Neurol"},{"key":"2266_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fphys.2016.00183","volume":"7","author":"CG Vasilopoulou","year":"2016","unstructured":"Vasilopoulou CG, Margarity M, Klapa MI (2016) Metabolomic analysis in brain research: opportunities and challenges. Front Physiol 7:183","journal-title":"Front Physiol"},{"issue":"1\u20132","key":"2266_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1155\/2006\/202938","volume":"22","author":"AN Fonteh","year":"2006","unstructured":"Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, Harrington MG (2006) Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 22(1\u20132):39\u201364","journal-title":"Dis Markers"},{"issue":"1","key":"2266_CR4","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1038\/s41598-020-63483-w","volume":"10","author":"SSD Rashad","year":"2020","unstructured":"Rashad SSD, Yamazaki T, Matsumoto Y, Tomioka Y, Saito R, Uruno A, Niizuma K, Yamamoto M, Tominaga T (2020) Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach. Sci Rep 10(1):6507","journal-title":"Sci Rep"},{"issue":"2","key":"2266_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jchromb.2008.05.001","volume":"871","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Lewis MJ, Morrissey JA et al (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Anal Technol Biomed Life Sci 871(2):164\u2013173","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"1","key":"2266_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainres.2006.05.057","volume":"1104","author":"B Toczy\u0142owska","year":"2006","unstructured":"Toczy\u0142owska B, Chalimoniuk M, Wodowska M, Mayzner-Zawadzk E (2006) Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury. Brain Res 1104(1):183\u2013189","journal-title":"Brain Res"},{"issue":"1","key":"2266_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34(1):173\u2013186","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"2266_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibtech.2004.03.007","volume":"22","author":"RVS Goodacre","year":"2004","unstructured":"Goodacre RVS, Dunn WB, Harrigan GG, Kell DB (2004) Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 22(5):245\u2013252","journal-title":"Trends Biotechnol"},{"issue":"2","key":"2266_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/092986713804806621","volume":"20","author":"MS Monteiro","year":"2013","unstructured":"Monteiro MS, Carvalho M, Bastos ML, de Guedes Pinho P (2013) Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem 20(2):257\u2013271","journal-title":"Curr Med Chem"},{"issue":"5","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/bib\/bbm030","volume":"8","author":"DS Wishart","year":"2007","unstructured":"Wishart DS (2007) Current progress in computational metabolomics. Brief Bioinform 8(5):279\u2013293","journal-title":"Brief Bioinform"},{"issue":"10","key":"2266_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/metabo10100389","volume":"10","author":"ACA Donatti","year":"2020","unstructured":"Donatti ACA, Godoi AB, da Rosa DC, Lopes-Cendes I (2020) Circulating metabolites as potential biomarkers for neurological disorders-metabolites in neurological disorders. Metabolites 10(10):389","journal-title":"Metabolites"},{"key":"2266_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fphys.2016.00183","volume":"7","author":"CG Vasilopoulou","year":"2016","unstructured":"Vasilopoulou CG, Margarity M, Klapa MI (2016) Metabolomic analysis in brain research metabolomic analysis in brain research: opportunities and challenges. Front Physiol 7:183","journal-title":"Front Physiol"},{"key":"2266_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fneur.2017.00438","volume":"8","author":"B Sok\u00f3\u0142","year":"2017","unstructured":"Sok\u00f3\u0142 B, Urbaniak B, W\u0105sik N, Plewa S, Klupczy\u0144ska A, Jankowski R, Wi\u0119ckowska B, Juszkat R, Kokot Z (2017) Amino acids in cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage: an observational study. Front Neurol 8:438","journal-title":"Front Neurol"},{"issue":"6","key":"2266_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/02688697.2018.1519107","volume":"32","author":"A DE Lu","year":"2017","unstructured":"DE Lu A, Winkler E, Grant R, Eid T, Bulsara K (2017) Cerebrospinal fluid untargeted metabolomic profiling of aneurysmal subarachnoid hemorrhage: an exploratory study. Br J Neurosurg 32(6):637\u2013641","journal-title":"Br J Neurosurg"},{"key":"2266_CR15","first-page":"25","volume":"19","author":"B Daviss","year":"2005","unstructured":"Daviss B (2005) Growing poains for metabolomics. Scientist 19:25\u201328","journal-title":"Scientist"},{"key":"2266_CR16","doi-asserted-by":"crossref","unstructured":"Ho W, Goerke AS, Glodny B, Oberacher H, Helbok R, Thome C, Petr O. Time Course of Metabolomic Alterations in CSF after aneurysmal Subarachnoid Hemorrhage. Frontiers in neurology. 2020","DOI":"10.3389\/fneur.2020.00589"},{"issue":"3","key":"2266_CR17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1021\/acschemneuro.8b00581","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Wang R, Xu M, Jing X, Sun R, Na S, Liu T, Ding X, Sun C, Ge W (2019) Aneurysmal subarachnoid hemorrhage onset alters pyruvate metabolism in poor-grade patients and clinical outcome depends on more: a cerebrospinal fluid metabolomic study. ACS Chem Neurosci 10(3):1660\u20131667","journal-title":"ACS Chem Neurosci"},{"key":"2266_CR18","unstructured":"Koch M, Acharjee A, Ament Z, Schleicher R, Bevers M, Stapleton C, Patei A, Kimberly T. Machine Learning-driven metabolomic evaluation of cerebrospinal fluid: insights into poor outcomes after aneurysmal subarachnoid hemorrhage."}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02266-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02266-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02266-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:14:36Z","timestamp":1701180876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02266-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02266-2","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,30]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Franziska A. Schmidt, conflict of interest: none, disclosure of funding: none; Wing Mann Ho, conflict of interest: none, disclosure of funding: none; Ondra Petr, conflict of interest: none, disclosure of funding: none; Claudius Thom\u00e9, conflict of interest: none, disclosure of funding: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}